Yao Su, Xu Fangping, Chen Yu, Ge Yan, Zhang Fen, Huang Huijie, Li Li, Lin Danyi, Luo Xinlan, Xu Jie, Luo Donglan, Zhu Xiaolan, Liu Yanhui
Department of Pathology, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, People's Republic of China.
Department of Pathology, Dongguan People's Hospital, Dongguan, Guangdong, 523059, People's Republic of China.
J Exp Clin Cancer Res. 2017 Jan 10;36(1):10. doi: 10.1186/s13046-016-0476-y.
The ubiquitin-ligase Fbw7 acts as a tumor suppressor, targeting lots of proto-oncogenes for proteolysis. However, the exact role of Fbw7 in diffuse large B-cell lymphoma (DLBCL) development remains unclear.
We evaluated Fbw7 expression in patient samples of DLBCL using immunohistochemical staining. The effect of Fbw7 overexpression on cell viability and apoptosis was investigated using activated B-cell (ABC) like DLBCL cell lines. The mechanism of Fbw7 activity in DLBCL was investigated using immunoprecipitation, ubiquitination, western blot and qualitative analyses.
The non-germinal center B-cell-like subtype of DLBCL showed reduced Fbw7 expression compared with the germinal center B-cell (GBC) subtype, and low Fbw7 expression was associated with a worse prognosis. Fbw7 overexpression caused decreased cell viability and increased apoptosis rates in the ABC-DLBCL cell lines SU-DHL-2 and OCI-LY-3. Importantly, Stat3 and phospho-Stat3 stability were reduced following Fbw7 overexpression in ABC-DLBCL cell lines. In HEK293T and SU-DHL-2 cells, we demonstrated that Fbw7 interacts with Stat3 and pStat3 to regulate their ubiquitylation and degradation. Downstream anti-apoptotic target genes of activated Stat3, including Myc, Survivin, Mcl-1, Pim-1, Bcl-2 and Bcl-xl showed decreased mRNA expression following exogenous Fbw7 overexpression. The negative relationship between Fbw7 and pStat3 levels was also confirmed in DLBCL patient samples.
The ubiquitin-ligase Fbw7 mediates apoptosis through targeting Stat3 for ubiquitylation and degradation in ABC-DLBCL. Thus, our study may offer a promising approach for ABC-DLBCL therapy through Stat3 inhibition.
泛素连接酶Fbw7作为一种肿瘤抑制因子,靶向许多原癌基因进行蛋白水解。然而,Fbw7在弥漫性大B细胞淋巴瘤(DLBCL)发展中的确切作用仍不清楚。
我们使用免疫组织化学染色评估DLBCL患者样本中Fbw7的表达。使用活化B细胞(ABC)样DLBCL细胞系研究Fbw7过表达对细胞活力和凋亡的影响。使用免疫沉淀、泛素化、蛋白质印迹和定性分析研究Fbw7在DLBCL中的活性机制。
与生发中心B细胞(GBC)亚型相比,DLBCL的非生发中心B细胞样亚型显示Fbw7表达降低,且Fbw7低表达与较差的预后相关。Fbw7过表达导致ABC-DLBCL细胞系SU-DHL-2和OCI-LY-3的细胞活力降低和凋亡率增加。重要的是,在ABC-DLBCL细胞系中Fbw7过表达后,Stat3和磷酸化Stat3的稳定性降低。在HEK293T和SU-DHL-2细胞中,我们证明Fbw7与Stat3和pStat3相互作用以调节它们的泛素化和降解。活化Stat3的下游抗凋亡靶基因,包括Myc、Survivin、Mcl-1、Pim-1、Bcl-2和Bcl-xl在外源Fbw7过表达后显示mRNA表达降低。Fbw7与pStat3水平之间的负相关关系在DLBCL患者样本中也得到证实。
泛素连接酶Fbw7通过靶向Stat3进行泛素化和降解来介导ABC-DLBCL中的细胞凋亡。因此,我们的研究可能通过抑制Stat3为ABC-DLBCL治疗提供一种有前景的方法。